Ethyl 4-(5-Bromo-3-(piperidin-1-ylmethyl)-1H-indol-1-yl)-butanoate

ID: ALA4583861

Chembl Id: CHEMBL4583861

PubChem CID: 155565912

Max Phase: Preclinical

Molecular Formula: C20H27BrN2O2

Molecular Weight: 407.35

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)CCCn1cc(CN2CCCCC2)c2cc(Br)ccc21

Standard InChI:  InChI=1S/C20H27BrN2O2/c1-2-25-20(24)7-6-12-23-15-16(14-22-10-4-3-5-11-22)18-13-17(21)8-9-19(18)23/h8-9,13,15H,2-7,10-12,14H2,1H3

Standard InChI Key:  CNGAYQLORBGMNE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4583861

    ---

Associated Targets(Human)

CACNA1H Tclin Voltage-gated calcium channel (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cortical neurone (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.35Molecular Weight (Monoisotopic): 406.1256AlogP: 4.73#Rotatable Bonds: 7
Polar Surface Area: 34.47Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.73CX LogP: 4.36CX LogD: 3.86
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.62Np Likeness Score: -1.37

References

1. Lajarín-Cuesta R, Nanclares C, Arranz-Tagarro JA, González-Lafuente L, Arribas RL, Araujo de Brito M, Gandía L, de Los Ríos C..  (2016)  Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.,  59  (13): [PMID:27280380] [10.1021/acs.jmedchem.6b00478]

Source